Geovax Labs, Inc. completed a registered direct offering on March 25, 2025, selling 1,350,000 shares at $1.31 each and raising approximately $4.1 million for working capital. Additionally, they amended existing warrants to reduce their exercise price to $1.31 and extend their expiration to March 25, 2030.